ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2060

Comparative Histologic and Molecular Analysis of Synovial Tissue in Early Treatment-Naïve Psoriatic and Rheumatoid Arthritis

Alessandra Nerviani1, Frances Humby1, Gloria Lliso Ribera1, Wang Sin Tan1, Marie Astrid Boutet1, Katriona Goldmann1, Fabiola Bene1, Rebecca Hands1, Stephen Kelly2, Michele Bombardieri3, Myles J. Lewis3, Chris Buckley4, Peter C. Taylor5, Iain B. McInnes6 and Costantino Pitzalis1, 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 2Rheumatology Department, Barts Health NHS Trust, London, London, United Kingdom, 3Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, United Kindgdom, London, United Kingdom, 4Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham, United Kingdom, 5University of Oxford Botnar Research Centre, Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 6Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: psoriatic arthritis and rheumatoid arthritis (RA), Synovial Immune Biology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) are chronic joint conditions characterised by persistent inflammation of the synovial tissue (ST). Previous reports suggested less marked synovial lining and fewer infiltrating T cells in PsA compared to RA. Several confounders such as disease duration, treatment, sampling techniques and a predominance of large joints samples may have influenced these findings. Here we aimed at comparing the synovial features of RA/PsA early in the disease and prior to treatment intervention to highlight their histologic and molecular individual characteristics.

Methods: 183 consecutive patients with early (<12 months) treatment-naïve arthritis and active synovitis of at least one joint were recruited as part of the multicentre Pathobiology of Early Arthritis Cohort (PEAC) at the Barts Health NHS Trust and underwent a baseline US-guided synovial biopsy of an actively inflamed joint. ST inflammatory infiltrate was evaluated by H&E and semi-quantitative score (0-4) of the immunostaining for CD68 (macrophages), CD3 (T cells), CD20 (B cells) and CD138 (plasma cells). Patients were classified as: Pauci-immune, CD68sublining (SL)<2 and/or CD3-CD20-CD138<1; diffuse-myeloid, CD68SL>2, CD20<2 or CD138<2; lympho-myeloid, CD20>2 or CD138>2. RNA sequencing was performed on 93 RA/15 PsA patients.

Results:

144/183 patients met the 2010ACR/EULAR criteria for RA and 39/183 were diagnosed with PsA (32 polyarticular 7 oligoarticular). PsA patients were significantly younger than RA. Comparison of the age-adjusted clinical variables at baseline showed no significant differences between ESR, CRP and DAS28, despite a significantly higher number of tender and swollen joints in RA. ST was retrieved from small joints in 74.4% of PsA and 82% of RA. US score of the biopsied joints showed a significantly higher synovial thickening in the PsA group and comparable power-doppler. Histopathology assessment showed a significantly lower infiltration of B/T lymphocytes, plasma cells and SL-macrophages in psoriatic synovitis. The distribution of synovial pathotypes also differed, as the pauci-immune was the most represented in PsA (43.2%) but the least frequent in RA (24.8%). Only in RA, the pauci-immune pathotype associated with significantly lower ESR, CRP and DAS28 in comparison with lympho-myeloid; these differences remained significant also in a subset of 26 RA subjects age- and gender-matched with PsA patients. Conversely, pathotypes did not define less active disease in PsA. Cellular gene modules analysis showed the expression of neutrophil, eosinophil and mast cell gene-sets in PsA but not RA pauci-immune synovitis. Overall, PsA ST differed from RA with a higher expression of the skin fibroblasts, eosinophils and neutrophils gene-sets. Finally, genes significantly up-regulated in PsA clustered in specific modules including neutrophil recruitment/enrichment and cytoskeleton remodelling.

Conclusion:

The demonstration of specific histological and molecular signatures relating to early-untreated PsA and RA will help to shed new light on disease pathogenesis and identify novel therapeutic targets.


Disclosure: A. Nerviani, None; F. Humby, None; G. Lliso Ribera, None; W. S. Tan, None; M. A. Boutet, None; K. Goldmann, None; F. Bene, None; R. Hands, None; S. Kelly, None; M. Bombardieri, None; M. J. Lewis, None; C. Buckley, None; P. C. Taylor, None; I. B. McInnes, None; C. Pitzalis, None.

To cite this abstract in AMA style:

Nerviani A, Humby F, Lliso Ribera G, Tan WS, Boutet MA, Goldmann K, Bene F, Hands R, Kelly S, Bombardieri M, Lewis MJ, Buckley C, Taylor PC, McInnes IB, Pitzalis C. Comparative Histologic and Molecular Analysis of Synovial Tissue in Early Treatment-Naïve Psoriatic and Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/comparative-histologic-and-molecular-analysis-of-synovial-tissue-in-early-treatment-naive-psoriatic-and-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparative-histologic-and-molecular-analysis-of-synovial-tissue-in-early-treatment-naive-psoriatic-and-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology